Oral tranexamic acid for the treatment of melasma: evidence and experience-based consensus statement from Indian experts

Oral tranexamic acid for the treatment of melasma: evidence and experience-based consensus statement from Indian experts

Melasma, a chronic pigmentary skin condition mainly affecting the face, remains a challenge despite the availability of several options for treatment. Many melasma patients are not satisfied with treatment outcomes. Tranexamic acid (TXA), an anti-fibrinolytic drug has shown promising results in pati...

Full description

Bibliographic Details
Main Authors: Kiran Godse, Rashmi Sarkar, Venkataram Mysore, Manunath M Shenoy, Manas Chatterjee, Rajetha Damisetty, Swapnil Shah, Maya Vedamurthy, Sanjeev Aurangabadkar, Chakravarthi Srinivas, Anil Ganjoo, Sudip Das, Anant Patil
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Indian Journal of Dermatology
Subjects:
adverse event
anti-fibrinolytic agent
evidence
treatment outcome
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2023;volume=68;issue=2;spage=178;epage=185;aulast=Godse

Internet

http://www.e-ijd.org/article.asp?issn=0019-5154;year=2023;volume=68;issue=2;spage=178;epage=185;aulast=Godse

Similar Items